Tech Company Financing Transactions
Accera Funding Round
Accera closed a $17.6 million financing round on 3/27/2018. Investors included private investors.
Transaction Overview
Company Name
Announced On
3/27/2018
Transaction Type
Venture Equity
Amount
$17,639,537
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3005 Center Green Dr. 205
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
Accera is a clinical stage biotechnology company developing therapies for central nervous system disorders including Alzheimer's disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charles Stacey
Chief Financial Officer
Evan Ballantyne
Chief Medical Officer
Judy Walker
VP - Bus. Development
Ernest Wong
VP - Finance
Jerris Knaisch
VP - R & D
Samuel Henderson
Browse more venture capital transactions:
Prev: 3/27/2018: Embotics venture capital transaction
Next: 3/27/2018: Cardinal Analytx Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs